A 53-year-old man with untreated, advanced HIV and a CD4 count of 7 cells/mm 3 was diagnosed with progressive multifocal leukoencephalopathy (PML) following a fourweek prodrome of progressive confusion, ataxia, and dysarthria. During evaluation, he was also found to have large pulmonary nodules on computed tomography (CT) of the chest concerning for a granulomatous infection or malignancy (Fig. 1) . Biopsy revealed fungal organisms on Gomori methenamine silver (GMS) stain, consistent with Pneumocystis species. The patient was started on trimethoprim/ sulfamethoxazole and highly active antiretroviral therapy (HAART) therapy, but expired of his progressive PML. An autopsy confirmed Pneumocystis jirovecii within the pulmonary nodules, but no malignancy (Fig. 2) . In HIV patients, Pneumocystis jirovecii presents with bilateral interstitial ground-glass opacities in approximately 90 % of patients. Additionally, atypical presentations are well described and may include cysts (30 %), lymphadenopathy (10 %), small or large nodules (5 %), and rarely consolidations or a spontaneous pneumothorax. 1, 2 Due to the wide range of radiologic findings associated with Pneumocystis jirovecii, diagnostic confirmation can be obtained via tissue biopsy. In a patient whose CD4 count is below 200 cells/mm 3 , Pneumocystis jirovecii prophylaxis with trimethoprim/sulfamethoxazole is indicated regardless of diagnostic uncertainty. Clinicians should be aware of atypical presentations of Pneumocystis jirovecii, as they may be confused with malignancy, granulomatous processes, or other lung disease. 
